FDA Inspection
Minaris Regenerative Medicine, LLCMinaris Regenerative Medicine, LLC – FDA Inspection, Sep 29, 2025
Record Details
This FDA Inspection record concerns Minaris Regenerative Medicine, LLC, with an inspection on September 29, 2025, issued by the New Jersey District Office, covering biologics.
View Company Profile
ID · 9080b763-c431-455a-aed1-0c069db6f2aa
Inspection Facts
- Inspection number
- 1284408
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.188(b)(2)Identity of major equipment and lines used
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Minaris Regenerative Medicine, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2023 | Not classified | New Jersey District Office | |
| August 26, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 26, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 17, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Minaris Regenerative Medicine, LLC
- FDA Inspection 1224145 - 2023-09-25
- FDA Inspection 1101234 - 2019-08-26
- FDA Inspection 1020396 - 2017-04-26
- FDA Inspection 886646 - 2014-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.